NCT00910559Active, not recruiting
Phenotypic and Genetic Factors in Autism Spectrum Disorders
Source: ClinicalTrials.gov · Last updated 29 Dec 2025
Brief summary (registry, in English)
The purpose of the study is to collect phenotypic (observable characteristics) and genetic information about individuals with Autism Spectrum Disorders (ASDs) and their families.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 1500 (estimated)
- First submitted
- 29 May 2009
- Start date
- 1 Jul 2008
- Primary completion date
- 31 Jan 2028
- Lead sponsor
- Boston Children's Hospital
- Diseases
- Autism
- NCT number
- NCT00910559
What you commit to
- Study type: Observational
- Planned participants: 1500
- From 1 Jul 2008 to the primary completion date, 31 Jan 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of a metabolic disorder
Other
- Acquired developmental disability (e.g., birth asphyxia, trauma-related injury, meningitis, etc.) or cerebral palsy
Who the study is looking for
- Diagnosis of autism spectrum disorder or suspected diagnosis based on clinical genetic test results (e.g., variant diagnosed via chromosomal microarray)
- Age ≥ 18 months
Age in the registry: 18 months to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Children's Hospital, Boston Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.